[1] STRUZ F, OKADA H, LO C W. Idantification and characterization of a fibroblast marker:FSP1. 1995. doi:10.1083/jcb.130.2.393
[2] ALCOM D, MARIC J, MCCAUSLAND J. Development of the renal interstitium. 1999. doi:10.1007/s004670050624
[3] EDDY A A. Can renal fibrosis be reversed?. 2005(10). doi:10.1007/s00467-005-1995-5
[4] LIU B C, ZHANG J D, ZHANG X L. Role of connective tissure growth factor(CTGF)module 4 in regulating epithelial-myofibroblast transdifferentiation (EMT) in HK-2 cells. 2006(1/2). doi:10.1016/j.cca.2006.05.029
[5] DEMIR A Y, GROOTHUIS P G, GUNSELMAN G A. Molecular characterization of soluble factors from human menstrual effluent that induces epithelial to mesenchymal transitions in mesothelial cells. 2005. doi:10.1007/s00441-005-0002-6
[6] FAN J M, HUANG X R, NG Y Y. Interluekin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. 2001(4). doi:10.1016/S0272-6386(1)80132-3
[7] CHENG S, LOVETT D H. Gelatinase A(MMP-2) is necessary and sufficient for Renal tubular cell epithelial-myofibroblast transdifferentiation. 2003
[8] OKADA H, KALLURI R. Cellular and molecular pathways that lead to progression and regression of renal fibrogenesis. 2005(5). doi:10.2174/1566524054553478
[9] NIGHTINGALE J, PATEL S, SUZUKI N. Oncostatin M,a cytokine released by activated mononuclear cells,induces epithelial cell-myofibroblast transdifferentiation via Jak/Stat pathway activation. 2004(1). doi:10.1097/01.ASN.0000102479.92582.43
[10] MANOHAM K, TANAKA T, MATSUMOTO M. Transdifferentiation of cultured tubular cells induced by hypoxia. 2004. doi:10.1111/j.1523-1755.2004.00461.x
[11] BOTTINGER E P, BITZER M. TGF-β signaling in renal disease. 2002(10). doi:10.1097/01.ASN.0000033611.79556.AE
[12] PHANISH M K, WAHAB N A, COLVILLE-NASH P. The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGF beta1 responses in human proximal-tubule epithelial cells. 2006(2). doi:10.1042/BJ20051106
[13] DELCOMMENNE M, TAN C, GRAY V. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by integrin linked kinase. 1998(19). doi:10.1073/pnas.95.19.11211
[14] BACHELDER R E, YOON S O, FRANCI C. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription:implications for the epithelial-mesenchymal transition, 2005
[15] LIU Y. Epithelial to mesenchymal transition in renal fibrogenesis:pathologic significance,mocularmechanisms and therapeutic intervention. 2004(1). doi:10.1097/01.ASN.0000106015.29070.E7
[16] PATEL S, TAKAGI K I, SUZUKI J. RhoGTPase activation is a key step in renal epithelial mesenchymal transdifferentiation. 2005(7). doi:10.1681/ASN.2004110943
[17] RHYU D Y, YANG Y, HA H. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. 2005(3). doi:10.1681/ASN.2004050425
[18] LI Y, YANG J, LUO J H. Tubular epithelial cell differentiation is driven by the helix-loop-helix transcription inhibitor Id1. 2007. doi:10.1681/ASN.2006030236
[19] KOWANETZ M, VALCOURT U, BERGSTROM R. ld2 and Id3 define the potency of cell proliferation and differentiation responses totransforming growth factor beta and bone morphogenetic protein. 2004. doi:10.1128/MCB.24.10.4241-4254.2004
[20] LABBE E, LETAMENDIA A, ATTSANO L. Association of Smads with lymphoid enhancer binding factor1/T cell specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways, 2000
[21] BARBERA M J, PUIG I, DOMINGUEZ D. Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. 2004(44). doi:10.1038/sj.onc.1207990
[22] MASSZI A, FAN L, ROSIVALL L. Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition:role for beta-catenin. 2004(6)
[23] TYLER J R, ROBERTSON H, BOOTH T A. Chronic allograft nephropathy:intraepithelial signals generated by transforming growth factor-beta and bone morphogenetic protein-7. 2006(6). doi:10.1111/j.1600-6143.2006.01339.x
[24] YANG J, DAI C, LIU Y. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. 2005. doi:10.1681/ASN.2003090795
[25] LIU Y. Renal fibrosis:new insights into the pathogenesis and therapeutics. 2006. doi:10.1038/sj.ki.5000054
[26] LAN H Y, M U W, TOMITA N. Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. 2003(6). doi:10.1097/01.ASN.0000067632.04658.B8
[27] YSHIKAWA M, HISHIKAWA K, MAREMO T. Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta 1 in human renal epithelial cells, 2007
[28] LIN J, PATEL S R, CHENG X. Kielin/chordin-like protein,a novel enhancer of BMP signaling attenuates renal fibrotic disease. 2005. doi:10.1038/nm1217
[29] CHEN L, LIU B C, ZHANG X L. Influence of connective tissure growth factor antisense oligonucleotide on angiotensin Ⅱ-induced epithelial to myofibroblast transition in HK-2 cells. 2006(8). doi:10.1111/j.1745-7254.2006.00344.x
[30] LIN S L, CHEN R H, CHEN Y M. Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor. 2005(9). doi:10.1681/ASN.2005040435
[31] ZHOU B P, DENG J, XIA W. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial to mesenchymal transition. 2004(10). doi:10.1038/ncb1173
[32] NAGATOYA K, MORIYAMA T, KAWADA N. Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral bstruction. 2002. doi:10.1046/j.1523-1755.2002.00328.x |
